Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-05-19
1985-11-12
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546120, A61K 3144, C07D47104
Patent
active
045528837
ABSTRACT:
Compounds of the formula (I): ##STR1## wherein R.sup.1, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 have defined values and the N-oxides at the 7-position of the pyrazolo[3,4-b]pyridine ring system and the pharmaceutically-acceptable acid-addition salts thereof, processes for their preparation and use, pharmaceutical compositions, and intermediates for preparing said compounds of the formula (I). The compounds of formula (I) are central nervous system depressants, for example anxiolytic agents.
REFERENCES:
patent: 3755340 (1973-08-01), Hoehn et al.
patent: 3849411 (1974-11-01), Hoehn et al.
patent: 4364948 (1982-12-01), Heald et al.
Puar et al., J. of Pharm. Sciences, 67(6), Jun. 1978, pp. 850-853.
Dentz Bernard I.
ICI Americas Inc.
Jiles Henry R.
Miano Rosemary M.
LandOfFree
Pyrazolo[3,4-b]pyridine carboxylic acid esters and their pharmac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolo[3,4-b]pyridine carboxylic acid esters and their pharmac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo[3,4-b]pyridine carboxylic acid esters and their pharmac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1880393